ADVFN - ニュース

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/07/13	05 : 07	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AMEX:PED	PEDEVCO Corp New
2024/07/13	05 : 07	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PRKR	ParkerVision Inc (QB)
2024/07/13	05 : 07	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:PCAR	PACCAR Inc
2024/07/13	05 : 06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:ACN	Accenture Plc
2024/07/13	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:REI	Ring Energy Inc
2024/07/13	05 : 06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:TC	TuanChe Ltd
2024/07/13	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:VEEV	Veeva Systems Inc
2024/07/13	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:VST	Vistra Corp
2024/07/13	05 : 06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GLBE	Global E Online Ltd
2024/07/13	05 : 06	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:XRTX	XORTX Therapeutics Inc
2024/07/13	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IKNA	Ikena Oncology Inc
2024/07/13	05 : 06	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:DFFN	Diffusion Pharmaceuticals Inc
2024/07/13	05 : 06	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:MDIA	Mediaco Holding Inc
2024/07/13	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NX	Quanex Corp
2024/07/13	05 : 06	PR Newswire (Canada)	RBC Gestion mondiale d'actifs Inc. annonce les résultats de vente de juin pour les fonds RBC, les fonds PH&N et les fonds BlueBay	TSX:RY	Royal Bank of Canada
2024/07/13	05 : 06	PR Newswire (Canada)	RBC Gestion mondiale d'actifs Inc. annonce les résultats de vente de juin pour les fonds RBC, les fonds PH&N et les fonds BlueBay	NYSE:RY	Royal Bank of Canada
2024/07/13	05 : 06	Business Wire	Dynex Capital, Inc. Declares Monthly Common Stock Dividend of $0.13	NYSE:DX	Dynex Capital Inc
2024/07/13	05 : 05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NYSE:ELF	e l f Beauty Inc
2024/07/13	05 : 05	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:FRSX	Foresight Autonomous Holdings Ltd
2024/07/13	05 : 05	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:ACN	Accenture Plc
2024/07/13	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:WTW	Willis Towers Watson Public Ltd Company
2024/07/13	05 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GOOS	Canada Goose Holdings Inc
2024/07/13	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GLW	Corning Inc
2024/07/13	05 : 05	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:JPM-M	JP Morgan Chase and Co
2024/07/13	05 : 05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:TGT	Target Corp
2024/07/13	05 : 05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	AMEX:PED	PEDEVCO Corp New
2024/07/13	05 : 05	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HIBB	Hibbett Inc
2024/07/13	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABVC	ABVC BioPharma Inc
2024/07/13	05 : 05	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:XRTX	XORTX Therapeutics Inc
2024/07/13	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LIXT	Lixte Biotechnology Holdings Inc

1 2 3 4 5 6 7 8 9 10 次へ >>

Deutsche Telekom (QX)

JP Morgan Chase

US Dollar vs Yen

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約